Pseudomonas aeruginosa Toxins and Disease

A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".

Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 8141

Special Issue Editor


E-Mail
Guest Editor
Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
Interests: trauma; secondary bacterial infections; amyloids; cognitive dysfunction; chronic critical illness; GPCR trafficking/signaling

Special Issue Information

Pseudomonas aeruginosa is a common cause of nosocomial pneumonia (among other sites of infection) in intensive care units and immunocompromised individuals. A recent working group indicated that pneumonia is not only a localized, acute disease, but can cause non-pulmonary end-organ dysfunction that leads to deleterious long-term health consequences for patients. Interestingly, many of these effects are mediated by the virulent toxins and avoidance methods possessed by the bacterium. These methods include, but are not limited to, the type III secretion system, flagellin, mucin production, and quorum sensing. Although we know much about how these toxins function, there is still much to learn about how the bacterium uses these methods to cause infection and disease.

This Special Issue will focus on how Pseudomonas aeruginosa can lead to virulent infection, maintain a balance between colonization and infection, lead to short- and long-term end-organ dysfunction, and how its virulent toxins and avoidance methods play a role in these processes.

Assoc. Prof. Brant Wagener
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • toxins
  • Pseudomonas aeruginosa
  • Type III secretion system
  • cystic fibrosis
  • pneumonia
  • end-organ dysfunction
  • quorum sensing
  • virulence factors
  • mucus

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 1702 KiB  
Review
Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection
by Kierra S. Hardy, Maxx H. Tessmer, Dara W. Frank and Jonathon P. Audia
Toxins 2021, 13(12), 880; https://0-doi-org.brum.beds.ac.uk/10.3390/toxins13120880 - 09 Dec 2021
Cited by 11 | Viewed by 4004
Abstract
Pseudomonas aeruginosa is an opportunistic, Gram-negative pathogen and an important cause of hospital acquired infections, especially in immunocompromised patients. Highly virulent P. aeruginosa strains use a type III secretion system (T3SS) to inject exoenzyme effectors directly into the cytoplasm of a target host [...] Read more.
Pseudomonas aeruginosa is an opportunistic, Gram-negative pathogen and an important cause of hospital acquired infections, especially in immunocompromised patients. Highly virulent P. aeruginosa strains use a type III secretion system (T3SS) to inject exoenzyme effectors directly into the cytoplasm of a target host cell. P. aeruginosa strains that express the T3SS effector, ExoU, associate with adverse outcomes in critically ill patients with pneumonia, owing to the ability of ExoU to rapidly damage host cell membranes and subvert the innate immune response to infection. Herein, we review the structure, function, regulation, and virulence characteristics of the T3SS effector ExoU, a highly cytotoxic phospholipase A2 enzyme. Full article
(This article belongs to the Special Issue Pseudomonas aeruginosa Toxins and Disease)
Show Figures

Figure 1

16 pages, 1440 KiB  
Review
The Role of Pseudomonas aeruginosa Virulence Factors in Cytoskeletal Dysregulation and Lung Barrier Dysfunction
by Brant M. Wagener, Ruihan Hu, Songwei Wu, Jean-Francois Pittet, Qiang Ding and Pulin Che
Toxins 2021, 13(11), 776; https://0-doi-org.brum.beds.ac.uk/10.3390/toxins13110776 - 02 Nov 2021
Cited by 10 | Viewed by 3237
Abstract
Pseudomonas (P.) aeruginosa is an opportunistic pathogen that causes serious infections and hospital-acquired pneumonia in immunocompromised patients. P. aeruginosa accounts for up to 20% of all cases of hospital-acquired pneumonia, with an attributable mortality rate of ~30–40%. The poor clinical outcome of P. [...] Read more.
Pseudomonas (P.) aeruginosa is an opportunistic pathogen that causes serious infections and hospital-acquired pneumonia in immunocompromised patients. P. aeruginosa accounts for up to 20% of all cases of hospital-acquired pneumonia, with an attributable mortality rate of ~30–40%. The poor clinical outcome of P. aeruginosa-induced pneumonia is ascribed to its ability to disrupt lung barrier integrity, leading to the development of lung edema and bacteremia. Airway epithelial and endothelial cells are important architecture blocks that protect the lung from invading pathogens. P. aeruginosa produces a number of virulence factors that can modulate barrier function, directly or indirectly, through exploiting cytoskeleton networks and intercellular junctional complexes in eukaryotic cells. This review summarizes the current knowledge on P. aeruginosa virulence factors, their effects on the regulation of the cytoskeletal network and associated components, and molecular mechanisms regulating barrier function in airway epithelial and endothelial cells. A better understanding of these processes will help to lay the foundation for new therapeutic approaches against P. aeruginosa-induced pneumonia. Full article
(This article belongs to the Special Issue Pseudomonas aeruginosa Toxins and Disease)
Show Figures

Figure 1

Back to TopTop